CSIMarket Company Name, Ticker, Industry, else..


Evolent Health Inc   (NYSE: EVH)
Other Ticker:  
 


 

Evolent Health Inc

EVH's Financial Statements and Analysis



Evolent Health Inc increased first quarter of 2025 net loss per share of $-0.63 compare to net loss per share of $-0.22 recorded in the same quarter a year ago a decrease compare to $-0.27 realized in previous quarter.


first quarter of 2025
Earnings Per Share Revenues
$ -0.63 $  484 Mill
$-0.41     $-156M     -24.39 %



Evolent Health Inc 's Revenue fell by -24.39 % in first quarter of 2025 (Mar 31 2025) year on year, to $484 million and declined by -25.19 % sequentially.


Evolent Health Inc is

More on EVH's Income Statement



Evolent Health Inc in the first quarter of 2025 recorded net loss of $-64.618 million, an increase from net loss of $-17.280 million in I. Quarter a year ago.

Sequentially net loss advanced

More on EVH's Growth

Evolent Health Inc Inventories
EVH's Cash flow In the first quarter of 2025 company's net cash flow was $99 million, capital expenditures fell by -5.34760.74%, to $-9 millions compare to same quarter a year ago

More on EVH's Cash flow Statement


Evolent Health Inc does not pay out common stock dividend.

In trailing twelve-month period Evolent Health Inc earned $ 0.16 cash per share, on a free-cash flow basis .

Book value fell by -6.79 % sequentially to $8.11 per share, -48.05% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -7.54 per share from $ -7.10.

Company issued 0.28 million shares or 0.24 % in Mar 31 2025.


• More on EVH's Dividends

 Market Capitalization (Millions) 859
 Shares Outstanding (Millions) 115
 Total Debt (Millions $) 819
 Revenue (TTM) (Millions $) 2,399
 Net Income (TTM) (Millions $) -109
 Cash Flow (TTM) (Millions $) 44
 Capital Exp. (TTM) (Millions $) -28
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 4,700




Evolent Health Inc does not pay out common stock dividend.

In trailing twelve-month period Evolent Health Inc had $ 0.16 cash flow per share, on a free-cash flow basis .

Book value fell by -6.79 % sequentially to $8.11 per share, -48.05% of net loss per share in trailing twelve-month period were subtructed from shareholder value.
Tangible Book value fell to $ -7.54 per share from $ -7.10.

Company issued 0.28 million shares or 0.24 % in Mar 31 2025.


• More on EVH's Balance Sheets

 Market Capitalization (Millions) 859
 Shares Outstanding (Millions) 115
 Total Debt (Millions $) 819
 Revenue (TTM) (Millions $) 2,399
 Net Income (TTM) (Millions $) -109
 Cash Flow (TTM) (Millions $) 44
 Capital Exp. (TTM) (Millions $) -28
 Dividend TTM ($) 0 $
 Dividend Yield TTM (%) -
 Employees (TTM) $ 4,700
   


  News about Evolent Health Inc Earnings

Unexpected Turnaround: Evolent Health Inc. Surprises with Strong Financial Performance in Q1 2024

Evolent Health Inc. is ...

Evolent Health Inc Surges Ahead with Impressive Revenue Growth in Fourth Quarter of 2023

Despite reporting a deficit per share in the fourth quarter of 2023, Evolent Health Inc has shown tremendous growth in revenue, outperforming its industry competitors. The company's revenue surged by an impressive 45.4% compared to the same period last year, reaching $556.06 million. This strong growth in revenue is a clear indication of the company's success and potential for future expansion.
Furthermore, Evolent Health Inc's increase in accounts receivable suggests a rising demand for its services, which bodes well for its future financial performance. The company's net deficit may have widened compared to the previous year, but this can be attributed to the investments it has made in expanding its op...

Evolent Health Inc's Surging Revenue Fails to Bring Profitability, Raising Concerns for the Future



In the third quarter of the 2023 earnings season, Evolent Health Inc, an Internet Services and Social Media company, experienced mixed financial results. While the company saw a significant surge in revenue, its losses per share extended. This article will examine Evolent Health's performance in the context of the industry and provide insights into the company's future outlook.
Revenue Growth Outpaces Peers
Evolent Health Inc reported a remarkable revenue increase of 44.934% to $511.02 million compared to the corresponding period last year. This surge in revenue outpaced almost all other entities in the Internet Services and Social Media sector, which reported an average top-line improvemen...

Evolent Health Inc Reports Impressive 46.633% Q2 Revenue Spike, Outperforms Internet Services & Social Media Sector in 2023



In the second quarter of 2023, Evolent Health Inc, an Internet Services and Social Media company, experienced a significant surge in revenue by 46.633% to $469.14 million compared to the same quarter in the previous year. However, the company also saw an increase in its loss per share, with a reported figure of $-0.37 per share. This article aims to analyze Evolent Health Inc's financial results, taking into consideration its revenue growth, net loss, and market performance.
Revenue Growth Outperforms Sector Contemporaries:
Evolent Health's revenue surge in the second quarter of 2023 is indeed commendable, especially when compared to its competitors within the Internet Services and Social M...

Evolent Health Inc Surges with Impressive Top-line Growth in Q1 2023, Dominating the Internet Services & Social Media Industry

Evolent Health Inc Records Net Loss of $-34 Million, ROE Dips to -3.92%
Investors in Evolent Health Inc will be disappointed to learn that the company recorded a cumulative net loss of $-34 million during the 12 months ending in the first quarter of 2023. This resulted in a negative return on equity (ROE) of -3.92%, which is far from ideal for shareholders.
It's worth noting that within the Internet Services and Social Media industry, 11 other companies had a higher return on equity, indicating that there is significant competition in this space. Additionally, the company's total ranking has deteriorated compared to the fourth q...


Date modified: 2025-05-11T18:53:23+00:00





Help

About us

Advertise
CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright � 2025 CSIMarket, Inc. All rights reserved.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com